AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Teva Pharmaceutical Industries Ltd.

Regulatory Filings Nov 16, 2023

7082_rns_2023-11-16_780ff3c4-146d-4da6-af9e-e79cd6283cee.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

����� ����� � ����� ������� ���� ���� false

��� ������ ��������� ��"� 2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954 13365
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 16/11/2023
www.isa.gov.il www.tase.co.il Reference: 2023-02-104293 Time of broadcast: 14:42 14:42

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on����� ����� � ����� ������� ���� ����

Form_4__Vikki_Conway_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE Date of revision of form structure: 10/10/2023
Address: Dvora Hanevi'a 124 , Tel Aviv 6944020   , Tel: 03-9148262 , Fax: 03-9267519
E-mail address: [email protected]
Previous names of reporting entity:
Name of the Signatory: Kalif Eli Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Dvora Hanevia 124 , Tel Aviv 6944020 Telephone: 03-9148213 Facsimile: E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.